Search
Advanced Search

Framework Agreement For The Supply Of Drugs From The "Antineoplastic And Immunomodulatory" Group - 2 Lots - Trastuzumab Deruxtecan 100 Mg, Eribulinum 0.44 Mg/Ml, 2 Ml

ca

General Information
   Oct 16, 2024
   Romanian
   Other
   published: Oct 16, 2024

Original Text

TED 00626375-2024 - Result















Help Print Share





Share ×

Facebook X/Twitter LinkedIn Email

Cancel





.ted-toolbar {
display: flex;
}

.ted-mini-toolbar {
display: flex;
margin-bottom: 22px;
margin-left: auto;
}

.ted-help,
.ted-download,
.ted-print,
.ted-social-share {
background: none;
border: none;...
Subscription Options

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact Us

Contract award information
   FARMEXIM S.A. FARMEXIM S.A. FARMEXIM S.A. FARMEXIM S.A. FARMEXIM S.A. MEDIPLUS EXIM ALLIANCE HEALTHCARE ROMANIA FARMEXIM S.A. FARMEXIM S.A. FARMEXIM S.A. MEDIPLUS EXIM MEDIPLUS EXIM MEDIPLUS EXIM MEDIPLUS EXIM MEDIPLUS EXIM MEDIPLUS EXIM FILDAS TRADING MEDIPLUS EXIM ALLIANCE HEALTHCARE ROMANIA MEDIPLUS EXIM MEDIPLUS EXIM MEDIPLUS EXIM
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any suggestions for updates/corrections for this notice, please let us know.